Motivation Matters! study for HIV treatment
Part of Infections clinical trials.
This study tests a program called Motivation Matters! to help people with HIV who have traded sex for things they need get started on HIV medication and stay healthy. It uses text messages to support you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have exchanged sex for money, drugs, or something else you needed in the past year (transactional sex)
- You have HIV and you are not currently taking HIV medication (ART)
- You are a patient at one of the Sex Workers Outreach Program clinics
- You have a mobile phone and are willing to get study text messages
- You can read or have someone you trust read messages to you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a phone-based app to help young people with HIV stay on track with their care and treatment. If you join, you may get extra support to stay healthy.
This study tests a mobile app called Nishauri that may help men with HIV stick to their treatment and improve their health outcomes.
This study tests whether regular text messages and small rewards help teenagers keep taking their HIV medicine every day. It aims to make it easier for teens to stay healthy and stick with their treatment.
This study tests a program that uses text messages and a personal health coach to help Latino men with HIV take their medication every day. It's designed for those who have had trouble sticking to their HIV medicine routine.
This study tests whether daily text message reminders and a small tracking device (WisePill) can help people who recently started HIV medication stay on track. It's designed for people who began treatment in the past 2 months and are willing to receive texts and use the device.
This trial tests an mHealth (phone-based) program to help women with HIV improve health outcomes. It targets people who have had recent challenges with clinic visits, detectable virus levels, or taking HIV medicines.
Hear when a new HIV Antiretroviral Therapy (ART) Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.